Search
InsiderInsights.com

Christopher Nishan Garabedian (1492604)

Christopher Nishan Garabedian has been a registered insider since 2003. As Chief Executive Officer at AVI BioPharma, Inc., Christopher Nishan Garabedian last made a transaction on 2/27/2015.

Sarepta Therapeutics, Inc. (AVII, SRPT)

Titles: PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 50% -95% -15% 262 1 Year 2 50% -67% -- 310
2 50% -44% 62% 431 9 Month 2 50% -80% -- 270
3 67% 49% 18% 198 6 Month 3 67% 27% 40% 60
3 100% 79% 88% 144 3 Month 3 67% 95% 142% 149
3 100% 28% 10% 61 1 Month 3 67% 77% 115% 168
3 100% 16% 9% 36 1 Week 3 67% 66% 99% 165
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/13/2023 07:30 PM EST Latest Transaction Date: 2/27/2015
Average days between Transaction and Entered Dates: 2
© 2024 InsiderInsights.com